News FIR ordered against Snapdeal, CEO Kunal Bahal for allegedly selling prescription drugs

Deepu

EntMnt Legend
Finest Member
Maharashtra's Food and Drugs Administration (FDA) said it has ordered filing of FIR against e-commerce major Snapdeal.com's CEO Kunal Bahl and directors of the company in a case related to alleged online sale of medicines, including prescription drugs.

FDA Commissioner Harshadeep Kamble told reporters here that filing of an FIR has been ordered against Bahl as well as directors of Snapdeal.

When contacted, the company spokesperson did not offer any immediate comment.

FIR ordered against Snapdeal, CEO Kunal Bahal for allegedly selling prescription drugs - IBNLive
 
Top